Influenza Virus clinical trials

Explore recruiting influenza virus clinical trials.

Recruiting influenza virus studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Influenza Virus trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 2a Randomized, Double-blind, Placebo-controlled Trial with Open-label Dose-finding Cohorts to Evaluate the Efficacy and Safety of CR9114 Monoclonal Antibody Administered as Intranasal Doses in Healthy Adult Participants who are Challenged with a Live, Wild-type Influenza Type A Virus (A/Belgium/4217/2015 H3N2)

Belgium

Therapeutic exploratory (Phase II) EU CTIS Study details

Study to Learn How Safe EV25 is and the Amount of EV25 in the Body Over a Period of Time, When Taken [CCI] as a Dry Powder via the Nose by Adult Healthy People

Belgium

Human Pharmacology (Phase I)- Other EU CTIS Study details

A Phase 3/3b, Randomized, Observer-blind, Multicenter Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of Fluad and Fluad Quadrivalent Compared to a Non-adjuvanted Influenza Vaccine in Adults ≥65 Years of Age

Romania, Bulgaria, Finland, Spain, Poland, Netherlands +4 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Optimizing the time of day of influenza vaccine administration in adults aged 60-85 years: A randomized controlled trial

Netherlands

Therapeutic use (Phase IV) EU CTIS Study details

Immune responses to influenza vaccinations and viruses among health care personnel

Finland

Therapeutic use (Phase IV) EU CTIS Study details

A Phase IIIb Multicenter, Single-Arm, Open-Label Surveillance Study of Susceptibility to Baloxavir Marboxil in Pediatric Patients with Influenza and Transmission of Influenza to Household Contacts

Spain, Bulgaria, Poland

Therapeutic confirmatory (Phase III) EU CTIS Study details

Influenza Virus trials by city

Influenza Virus in Toronto Influenza Virus in Vancouver Influenza Virus in Montreal Influenza Virus in Calgary Influenza Virus in Edmonton Influenza Virus in Ottawa Influenza Virus in Winnipeg Influenza Virus in Quebec City Influenza Virus in Hamilton Influenza Virus in Kitchener Influenza Virus in London Influenza Virus in Halifax Influenza Virus in New York Influenza Virus in Los Angeles Influenza Virus in Chicago Influenza Virus in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease